Cargando…
Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?
Juvenile idiopathic arthritis (JIA) is one of the most frequent diseases in the practice of pediatric rheumatology. JIA treatments have been modified and improved with the use of biological drugs along with technological innovations. However, different types of hypersensitivity reactions to biologic...
Autores principales: | Kasap Cuceoglu, Muserref, Basaran, Ozge, Soyer, Ozge, Ozen, Seza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785630/ https://www.ncbi.nlm.nih.gov/pubmed/36555908 http://dx.doi.org/10.3390/jcm11247291 |
Ejemplares similares
-
Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
por: Kaya Akca, Ummusen, et al.
Publicado: (2021) -
Two siblings with Majeed syndrome and neutropenia
por: Kasap Cuceoglu, Muserref, et al.
Publicado: (2022) -
The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †
por: Basaran, Ozge, et al.
Publicado: (2023) -
Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods
por: Kaya Akca, Ümmüşen, et al.
Publicado: (2023)